kind of my type. three consecutive quarters profitable. turnaround is happening. grow from minus eps to profitable.
still undervalue if it's measured by PB industry, CR High. some products are also still haven't approved one of them is Alzheimer. if it's approved it's another breakthrough in medical science.
What will happen when Vanguard, Blackrock, Point72AM add position? 🚀
Only one product has already approved and marketed, it's profitable. What happens when it's all approved? it's kind of normal for small to mid$Biotechnology (LIST2069.US)$to be unprofitable, but this one is different.
Penny is always on OTC Market, bad fundamentally, less than a dollar or 5, no big institution like to invest, seriously this is not Penny,$Nu Holdings (NU.US)$, overvalued yes. but I hope not going to bubble.
Give some pullback or correction first la. Only opinion...
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more